4 Key Actions ClinOps Can Take Now to Avoid Disruptions
Biopharmaceutical sponsors should make urgent decisions now to plan for continued clinical research in the coming months.
How Pharma Can Work with the FDA to Embrace Innovation and Overcome Its “Adoptaphobia”
FDA commissioner Scott Gottlieb criticized pharmaceutical companies and clinical research organizations for being slow to adapt innovations in clinical research, claiming that the business model adopted just isn’t compatible with the kind of changes that certain innovations can enable.
How Data and Analytics Can Improve Clinical Trial Feasibility
These seven key building blocks for success are outlined to help companies develop and implement a data-and-analytics-driven approach to clinical trial feasibility.
2 Commerce Drive Cranbury, NJ 08512